Lozada, Salvacion L.
HRN: 05-23-70 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/20/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
04/20/2026
04/27/2026
IV
2.25 Gm
Q6H
Intra-abdominal
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines